Lay out the top 10 players in the telePrEP space by size; show which geographies (by state) each is strong or weak in; map all of their go-to-market channels and flag which are big or effective; and list their most successful campaigns.
This report covers a 10-brand national competitive set — all 10 requested slots — built from a live-web scan on 2026-10-03: 91 geography evidence rows and 857 GTM/campaign evidence rows, filtered to these brands and to PrEP-relevant activity. The ranking is a market-scale / evidence composite, not an audited patient-volume league table; the geography rows carry no coordinates, so states are matched by standardized names, and undisclosed figures are shown as “not publicly disclosed,” never zero.
Brands ordered by web-evidence visibility rank. Blue cells are channels where a row carries a numeric result (patients, conversions, reach, locations, market share); pale cells are channels in use whose effectiveness is not publicly quantified. Hover a cell for the evidenced channels behind it. PrEP-specific scale is distinguished from all-company scale.
Claimed state coverage per brand (company or comparison-page claims). Nationwide availability does not imply equal strength everywhere; explicit strong/weak evidence is rare and noted beside each bar. No weak states are inferred from missing evidence.
Ranked informally by weight of the measured result; the metric and date are shown with each. Campaigns with reach or future goals but no realized result sit in the strategic-bets note below. No PrEP-specific quantified campaign outcome is public for FOLX Health, Sistr, Wisp, Plume or TBD Health.
Every row links its source. “Scale type” says whether the disclosed figure is PrEP-specific or company-wide.
| Rank | Brand | Disclosed scale | Scale type | Coverage claim | Mentions | Hosts | Source |
|---|
Method: live-web scan conducted 2026-10-03 across roughly 1,600–1,900 unique pages per research stream; extracted sets hold 10 shortlist rows, 91 geography evidence rows and 857 GTM/campaign evidence rows, filtered here to the 10 national brands and PrEP-relevant channels (GLP-1, contraception, HRT and general telehealth marketing excluded). Rank is a public-evidence visibility composite, not audited market share; scale figures are company or source claims with dates preserved; conflicting claims are kept, not averaged; “not publicly disclosed” replaces zero. No coordinates in the data; geography maps by standardized state names. The shortlist is a national-brand set, not a census of local or state telePrEP programs. Some channel examples were cut for space; the matrix tooltips show up to two per cell.